vs
INTERPARFUMS INC（IPAR）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是INTERPARFUMS INC的1.6倍（$622.0M vs $386.2M），Royalty Pharma plc净利率更高（34.4% vs 7.3%，领先27.2%），INTERPARFUMS INC同比增速更快（6.8% vs 4.8%），过去两年INTERPARFUMS INC的营收复合增速更高（9.2% vs 4.6%）
Inter Parfums Inc是全球知名的高端香水企业，开发、生产并销售多款授权香水、身体护理及相关美妆产品，与多家顶级奢侈时尚生活方式品牌合作推出联名香氛系列，产品覆盖全球主要市场，通过百货、美妆专营店及官方电商渠道触达消费者。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
IPAR vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.6倍
$386.2M
营收增速更快
IPAR
高出2.0%
4.8%
净利率更高
RPRX
高出27.2%
7.3%
两年增速更快
IPAR
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.2M | $622.0M |
| 净利润 | $28.1M | $214.2M |
| 毛利率 | 61.5% | — |
| 营业利润率 | 7.1% | 62.4% |
| 净利率 | 7.3% | 34.4% |
| 营收同比 | 6.8% | 4.8% |
| 净利润同比 | 16.0% | 2.9% |
| 每股收益（稀释后） | $0.88 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IPARRPRX
| Q4 25 | $386.2M | $622.0M | ||
| Q3 25 | $429.6M | $609.3M | ||
| Q2 25 | $333.9M | $578.7M | ||
| Q1 25 | $338.8M | $568.2M | ||
| Q4 24 | $361.5M | $593.6M | ||
| Q3 24 | $424.6M | $564.7M | ||
| Q2 24 | $342.2M | $537.3M | ||
| Q1 24 | $324.0M | $568.0M |
净利润IPARRPRX
| Q4 25 | $28.1M | $214.2M | ||
| Q3 25 | $65.8M | $288.2M | ||
| Q2 25 | $32.0M | $30.2M | ||
| Q1 25 | $42.5M | $238.3M | ||
| Q4 24 | $24.2M | $208.2M | ||
| Q3 24 | $62.3M | $544.0M | ||
| Q2 24 | $36.8M | $102.0M | ||
| Q1 24 | $41.0M | $4.8M |
毛利率IPARRPRX
| Q4 25 | 61.5% | — | ||
| Q3 25 | 63.5% | — | ||
| Q2 25 | 66.2% | — | ||
| Q1 25 | 63.7% | — | ||
| Q4 24 | 64.5% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 64.5% | — | ||
| Q1 24 | 62.5% | — |
营业利润率IPARRPRX
| Q4 25 | 7.1% | 62.4% | ||
| Q3 25 | 25.3% | 70.1% | ||
| Q2 25 | 17.7% | 36.3% | ||
| Q1 25 | 22.2% | 94.0% | ||
| Q4 24 | 10.0% | 60.9% | ||
| Q3 24 | 25.0% | — | ||
| Q2 24 | 18.9% | 50.2% | ||
| Q1 24 | 21.0% | -13.0% |
净利率IPARRPRX
| Q4 25 | 7.3% | 34.4% | ||
| Q3 25 | 15.3% | 47.3% | ||
| Q2 25 | 9.6% | 5.2% | ||
| Q1 25 | 12.5% | 41.9% | ||
| Q4 24 | 6.7% | 35.1% | ||
| Q3 24 | 14.7% | 96.3% | ||
| Q2 24 | 10.8% | 19.0% | ||
| Q1 24 | 12.7% | 0.8% |
每股收益（稀释后）IPARRPRX
| Q4 25 | $0.88 | $0.49 | ||
| Q3 25 | $2.05 | $0.67 | ||
| Q2 25 | $0.99 | $0.07 | ||
| Q1 25 | $1.32 | $0.55 | ||
| Q4 24 | $0.78 | $0.46 | ||
| Q3 24 | $1.93 | $1.21 | ||
| Q2 24 | $1.14 | $0.23 | ||
| Q1 24 | $1.27 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $137.1M | $618.7M |
| 总债务越低越好 | $176.0M | $9.0B |
| 股东权益账面价值 | $880.7M | $9.7B |
| 总资产 | $1.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.20× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资IPARRPRX
| Q4 25 | $137.1M | $618.7M | ||
| Q3 25 | $77.5M | $938.9M | ||
| Q2 25 | $53.9M | $631.9M | ||
| Q1 25 | $75.3M | $1.1B | ||
| Q4 24 | $109.3M | $929.0M | ||
| Q3 24 | $78.8M | $950.1M | ||
| Q2 24 | $37.7M | $1.8B | ||
| Q1 24 | $76.1M | $843.0M |
总债务IPARRPRX
| Q4 25 | $176.0M | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $157.3M | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益IPARRPRX
| Q4 25 | $880.7M | $9.7B | ||
| Q3 25 | $870.9M | $9.6B | ||
| Q2 25 | $839.4M | $9.5B | ||
| Q1 25 | $788.6M | $9.8B | ||
| Q4 24 | $744.9M | $10.3B | ||
| Q3 24 | $778.5M | $10.3B | ||
| Q2 24 | $717.1M | $9.8B | ||
| Q1 24 | $708.1M | $9.9B |
总资产IPARRPRX
| Q4 25 | $1.6B | $19.6B | ||
| Q3 25 | $1.6B | $19.3B | ||
| Q2 25 | $1.6B | $18.3B | ||
| Q1 25 | $1.4B | $17.6B | ||
| Q4 24 | $1.4B | $18.2B | ||
| Q3 24 | $1.5B | $18.0B | ||
| Q2 24 | $1.4B | $17.7B | ||
| Q1 24 | $1.3B | $16.1B |
负债/权益比IPARRPRX
| Q4 25 | 0.20× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.21× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $146.5M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $145.0M | — |
| 自由现金流率自由现金流/营收 | 37.5% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | 5.21× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $190.5M | — |
8季度趋势，按日历期对齐
经营现金流IPARRPRX
| Q4 25 | $146.5M | $827.1M | ||
| Q3 25 | $63.9M | $702.6M | ||
| Q2 25 | $11.9M | $364.0M | ||
| Q1 25 | $-7.4M | $596.1M | ||
| Q4 24 | $138.0M | $742.5M | ||
| Q3 24 | $76.1M | $703.6M | ||
| Q2 24 | $25.5M | $658.2M | ||
| Q1 24 | $-52.0M | $664.6M |
自由现金流IPARRPRX
| Q4 25 | $145.0M | — | ||
| Q3 25 | $57.6M | — | ||
| Q2 25 | $-3.3M | — | ||
| Q1 25 | $-8.8M | — | ||
| Q4 24 | $136.1M | — | ||
| Q3 24 | $75.4M | — | ||
| Q2 24 | $24.4M | — | ||
| Q1 24 | $-53.0M | — |
自由现金流率IPARRPRX
| Q4 25 | 37.5% | — | ||
| Q3 25 | 13.4% | — | ||
| Q2 25 | -1.0% | — | ||
| Q1 25 | -2.6% | — | ||
| Q4 24 | 37.7% | — | ||
| Q3 24 | 17.8% | — | ||
| Q2 24 | 7.1% | — | ||
| Q1 24 | -16.4% | — |
资本支出强度IPARRPRX
| Q4 25 | 0.4% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.3% | — |
现金转化率IPARRPRX
| Q4 25 | 5.21× | 3.86× | ||
| Q3 25 | 0.97× | 2.44× | ||
| Q2 25 | 0.37× | 12.06× | ||
| Q1 25 | -0.17× | 2.50× | ||
| Q4 24 | 5.69× | 3.57× | ||
| Q3 24 | 1.22× | 1.29× | ||
| Q2 24 | 0.69× | 6.45× | ||
| Q1 24 | -1.27× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IPAR
| European Based Operations | $232.7M | 60% |
| United States Based Operations | $155.2M | 40% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
